Tatton Consulting supported Kensington and Chelsea-based Imperial College spinout developing Parkinson’s assessment technology SERG in its successful application to Biomedical Catalyst 2023 Round 1: Industry-led R&D, awarded £283,540 by Innovate UK for the project SERG ONE DBS – an intelligent mechanomyography sensor platform for precise, deep brain stimulation parametrisation to treat Parkinson’s Disease. The total Innovate UK grant across all project partners was £454,472.
About the funded R&D project
Deep brain stimulation can substantially reduce Parkinson’s symptoms, but setting the stimulation parameters correctly is a slow clinical process based on subjective assessment. SERG Technologies, an Imperial College spin-out, works with St George’s University Hospitals NHS Foundation Trust over 15 months to develop its patented TRL4 telemedicine assessment device into a mechanomyography sensor platform capable of informing that parametrisation objectively.
Award details
- Grant to SERG: £283,540
- Total project grant (all partners): £454,472
- Competition: Biomedical Catalyst 2023 Round 1: Industry-led R&D
- Competition year: 2023/24
- Project: SERG ONE DBS – an intelligent mechanomyography sensor platform for precise, deep brain stimulation parametrisation to treat Parkinson’s Disease
- Sector: Neurology / medical devices
- Independent verification: Innovate UK funded projects transparency dataset (UKRI), published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from Innovate UK’s published record of funded projects.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
